Company Update: Actavis plc (NYSE:ACT) – Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference
June 03, 2015 at 16:05 PM EDT
[PR Newswire] – DUBLIN, June 3, 2015 /PRNewswire/ — Actavis plc (NYSE: ACT), a leading global pharmaceutical company, today announced that Brent Saunders, CEO and President of Actavis, will provide an overview and . . . → Read More: Company Update: Actavis plc (NYSE:ACT) – Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference Similar Articles: Company Update: Actavis plc (NYSE:ACT) – Actavis cannot drop old version of Alzheimer’s drug – appeals court Stock Update (NYSE:ACT): Actavis Reports Exceptional Performance in First Quarter 2015 with 59% Increase in Net Revenue to $4.2 Billion and 23% Growth in Non-GAAP EPS to $4.30 Company Update (NYSE:ACT): (OFFICIAL)-UPDATE 1-Actavis’ superbug antibiotic gets U.S. approval (Feb. 25)
